Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 27

    Why DRUG PRICES are High: CCI Policy Paper on Healthcare

    Why DRUG PRICES are High: CCI Policy Paper on Healthcare

    Medical Dialogues Bureau27 Oct 2018 10:00 AM IST
    Competition Commission of India Brings Out Policy Note on ‘Making Markets Work for Affordable Healthcare’New Delhi: The Competition Commission of...
    USFDA not mandatory for Medical Devices: DOP releases Guideline for public procurement

    USFDA not mandatory for Medical Devices: DOP releases Guideline for public procurement

    Medical Dialogues Bureau22 Oct 2018 2:05 PM IST
    New Delhi: Giving relief to domestic medical device makers, the government has asked the procurement agencies to follow the Bureau of Indian Standards...
    Haryana: KARNAL to get Mega pharma park, says govt

    Haryana: KARNAL to get Mega pharma park, says govt

    Medical Dialogues Bureau17 Oct 2018 3:10 PM IST
    Chandigarh: The Haryana government Tuesday said a pharma park will be established over 100 acres of land in Karnal.Also, the state's Industries and...
    UP to open 6 pharma parks; gets Rs 5,000-6,000 Crore commitment

    UP to open 6 pharma parks; gets Rs 5,000-6,000 Crore commitment

    Medical Dialogues Bureau12 Oct 2018 2:24 PM IST
    The Uttar Pradesh government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000...
    Tamil Nadu hub for medical tourism : Banwarilal Purohit

    Tamil Nadu hub for medical tourism : Banwarilal Purohit

    Medical Dialogues Bureau12 Oct 2018 2:17 PM IST
    Chennai: Tamil Nadu has always been an important centre for medical diagnosis and treatment serves as a hub for medical tourism in the eastern part of...
    CDSCO launches Video Conferencing facility for promoting Pharmaceuticals Startups

    CDSCO launches Video Conferencing facility for promoting Pharmaceuticals Startups

    Medical Dialogues Bureau8 Oct 2018 2:02 PM IST
    All the stakeholders are informed to utilise this Video Conference facility by taking appointment along with details of the proposal in prescribed...
    NPPA told to revise prices of 3 Sun Pharma Formulations

    NPPA told to revise prices of 3 Sun Pharma Formulations

    Medical Dialogues Bureau30 Sept 2018 10:29 AM IST
    New Delhi: Through a recent order, the Department of Pharmaceutical has directed the NPPA to revise the prices of 3 Sun Pharma formulations, after the...
    Bahart Bandh: Nationwide strike by 8.5 lakh chemists and Retailers

    Bahart Bandh: Nationwide strike by 8.5 lakh chemists and Retailers

    Medical Dialogues Bureau29 Sept 2018 4:55 PM IST
    New Delhi: The all India chemist bandh that was organised yesterday at the behest of AIOCD indeed took a nationwide character after shutters were down...
    Unfair business ways: CCI Fine on Medical Device maker Esaote

    Unfair business ways: CCI Fine on Medical Device maker Esaote

    Medical Dialogues Bureau28 Sept 2018 10:20 AM IST
    New Delhi: The Competition Commission has penalised Italy's Esaote SpA and its group entity Esaote Asia Pacific Diagnostic for unfair business...
    Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

    Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

    Medical Dialogues Bureau27 Sept 2018 3:21 PM IST
    All the stakeholders are requested to forward their comments/ suggestions within a period of three weeks through e-mail to dci@nic.in...
    STRIKE ALERT: Chemists across India to keep doors shut on 28 September

    STRIKE ALERT: Chemists across India to keep doors shut on 28 September

    Medical Dialogues Bureau27 Sept 2018 2:07 PM IST
    We are observing one day strike on Friday, September 28, to protest any move by the government allowing the sale of medicines through an internet or...
    FIRST: Needle, syringe makers tell government to regulate their prices

    FIRST: Needle, syringe makers tell government to regulate their prices

    Medical Dialogues Bureau26 Sept 2018 3:41 PM IST
    New Delhi: All India Syringes and Needles Manufacturers Association (AISNMA) has written a letter to NELM on price capping of essential syringes and...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok